logo

For the Inventor, By the Inventor

Cape Coral, FL, United States of America

Linda Cahalan

USPTO Granted Patents = 10 

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:

goldMedal10 out of 14 
 
Ension Inc.
 patents

Years Active: 2012-2023

Loading Chart...
10 patents (USPTO):Explore Patents
1. 11622892 - Methods of making bioactive collagen wound care dressings (2023-04-11),
2. 10744039 - Methods of making bioactive collagen wound care dressings (2020-08-18),
3. 10512465 - Method and apparatus for coupling left ventricle of the heart to the anterior interventricular vein to stimulate collateral development in ischemic regions (2019-12-24),
4. 10456227 - Methods of surface treating tubular medical products (2019-10-29),
5. 9796769 - Methods of making bioactive collagen medical scaffolds such as for wound care dressings, hernia repair prosthetics, and surgical incision closure members (2017-10-24),
6. 9693841 - Surface treated staples, sutures and dental floss and methods of manufacturing the same (2017-07-04),
7. 9585665 - Method and apparatus for coupling left ventricle of the heart to the anterior interventricular vein to stimulate collateral development in ischemic regions (2017-03-07),
8. 9211369 - Compact integrated blood pump oxygenator or gas transfer device with hydrogel impeller packing material and rollover impeller outlet (2015-12-15),
9. 8343567 - Method of treating the surface of a medical device with a biomolecule (2013-01-01),
10. 8114465 - Process for preparing a substrate coated with a biomolecule (2012-02-14),

Title: Innovations by Linda Cahalan in Bioactive Collagen Technologies

Introduction

Linda Cahalan is a prominent inventor based in Cape Coral, Florida, known for her significant contributions to the field of bioactive collagen technologies. With a total of 10 patents to her name, she has made remarkable advancements in wound care dressings and medical scaffolds.

Latest Patents

One of her latest patents focuses on methods of making bioactive collagen wound care dressings. This innovative method involves immersing fibrous and/or non-fibrous collagen in a buffered acidic, aqueous solution containing alcohol. The collagen is then treated with a catalytic component, specifically 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride, to facilitate a reaction between amino and carboxyl groups present on the collagen. This process yields crosslinked collagen that is resistant to pronase degradation. The final product is a porous, crosslinked collagen article with a pore size ranging from 10 to 500 microns. Additionally, her patent includes bioactive collagen medical scaffolds designed for hernia repair prosthetics and surgical incision closure members.

Career Highlights

Linda Cahalan has established herself as a key figure in her field through her innovative research and development efforts. Her work at Ension Inc. has been instrumental in advancing medical technologies that improve patient outcomes.

Collaborations

Throughout her career, Linda has collaborated with notable colleagues, including Patrick Cahalan and Mark J Gartner, contributing to a dynamic and innovative work environment.

Conclusion

Linda Cahalan's contributions to bioactive collagen technologies exemplify her dedication to innovation in the medical field. Her patents not only enhance wound care but also pave the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…